| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Hematology-Oncology [W. M. R., E. C. D., A. T. L.], Pathology and Laboratory Medicine [S. C. P.], and Biochemical and Clinical Pharmacology [P. J. H.], St. Jude Children's Research Hospital, and the Division of Hematology-Oncology, Department of Pediatrics [W. M. R., E. C. D., A. T. L.], The University of Tennessee, Memphis, College of Medicine, Memphis, Tennessee
The gli gene, originally identified by its amplified copy number in cells from a human malignant glioma, has a predicted translation product that contains five tandem DNA-binding zinc finger motifs related to those of Krüppel, a developmentally important Drosophila segmentation gene. Because of the potential importance of overproduction of this protein in neoplastic development, we examined DNAs from 29 cases of childhood sarcoma for evidence of amplification of the gli gene. In one of the 13 rhabdomyosarcomas studied, genomic DNA restriction fragments containing the gli gene were amplified approximately 30-fold, and expression of the 4.0-kilobase gli mRNA transcript was identified. The tumor with gli gene amplification lacked the usual histological features of alveolar or embryonal rhabdomyosarcoma; however, ultrastructural analysis of tumor cells established in culture revealed attenuated sarcomeres, resembling those found in primitive rhabdomyoblasts. Cytogenetic analysis of this cell line disclosed double-minute chromatin bodies, with no apparent rearrangements in the region of the gli locus on the long arm of chromosome 12, bands q13 to q14.3. A 15-fold level of gli amplification and gli mRNA transcripts were also detected in an established cell line from a patient with a rare form of osteosarcoma characterized by multipotential histological features. A similar level of gli gene amplification was observed in cryopreserved primary tumor cells from this patient, confirming that gene amplification took place during tumor development and not during in vitro cell culture. Amplified gli sequences were cytogenetically localized by in situ hybridization to a homogeneously staining region contained on a derivative chromosome 7. Of eight osteosarcomas and seven Ewing's sarcomas with typical histopathological features, none had detectable rearrangements or amplification of gli sequences. Thus, gli gene amplification in childhood sarcomas appears restricted to tumors with primitive histopathological features, perhaps reflecting overproduction of a gene product able to influence gene expression during early mesenchymal cell development.
1 Supported in part by Grant CA-23099 and Cancer Center Support (CORE) Grant CA-21765 from the National Cancer Institute, NIH, and by the American Lebanese Syrian Associated Charities.
2 Supported by an American Society of Clinical Oncology Young Investigator Award. To whom requests for reprints should be addressed at Department of Hematology-Oncology, St. Jude Children's Research Hospital, P.O. Box 318, Memphis, TN 38101.
Received 5/15/89. Accepted 6/30/89.
This article has been cited by other articles:
![]() |
Z. Hu, J. M. Bonifas, G. Aragon, L. Kopelovich, Y. Liang, S. Ohta, M. A. Israel, D. R. Bickers, M. Aszterbaum, and E. H. Epstein Jr. Evidence for Lack of Enhanced Hedgehog Target Gene Expression in Common Extracutaneous Tumors Cancer Res., March 1, 2003; 63(5): 923 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dunaeva, P. Michelson, P. Kogerman, and R. Toftgard Characterization of the Physical Interaction of Gli Proteins with SUFU Proteins J. Biol. Chem., February 7, 2003; 278(7): 5116 - 5122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Allander, P. B. Illei, Y. Chen, C. R. Antonescu, M. Bittner, M. Ladanyi, and P. S. Meltzer Expression Profiling of Synovial Sarcoma by cDNA Microarrays : Association of ERBB2, IGFBP2, and ELF3 with Epithelial Differentiation Am. J. Pathol., November 1, 2002; 161(5): 1587 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Allander, N. N. Nupponen, M. Ringner, G. Hostetter, G. W. Maher, N. Goldberger, Y. Chen, J. Carpten, A. G. Elkahloun, and P. S. Meltzer Gastrointestinal Stromal Tumors with KIT Mutations Exhibit a Remarkably Homogeneous Gene Expression Profile Cancer Res., December 1, 2001; 61(24): 8624 - 8628. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gisselsson, T. Jonson, A. Petersen, B. Strombeck, P. Dal Cin, M. Hoglund, F. Mitelman, F. Mertens, and N. Mandahl Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors PNAS, September 26, 2001; (2001) 211357798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Smith, S. D. Gitlin, C. M. Browning, B. R. Lane, N. M. Clark, N. Shah, S. Rainier, and D. M. Markovitz GLI-2 Modulates Retroviral Gene Expression J. Virol., March 1, 2001; 75(5): 2301 - 2313. [Abstract] [Full Text] |
||||
![]() |
C. M. Browning, M. J. Smith, N. M. Clark, B. R. Lane, C. Parada, M. Montano, V. N. KewalRamani, D. R. Littman, M. Essex, R. G. Roeder, et al. Human GLI-2 Is a Tat Activation Response Element-Independent Tat Cofactor J. Virol., March 1, 2001; 75(5): 2314 - 2323. [Abstract] [Full Text] |
||||
![]() |
D. Gisselsson, J. Bjork, M. Hoglund, F. Mertens, P. Dal Cin, M. Akerman, and N. Mandahl Abnormal Nuclear Shape in Solid Tumors Reflects Mitotic Instability Am. J. Pathol., January 1, 2001; 158(1): 199 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Goyette, D. Allan, P. Peschard, C. F. Chen, W. Wang, and D. Lohnes Regulation of Gli Activity by All-trans Retinoic Acid in Mouse Keratinocytes Cancer Res., October 1, 2000; 60(19): 5386 - 5389. [Abstract] [Full Text] |
||||
![]() |
C. Wetmore, D. E. Eberhart, and T. Curran The Normal patched Allele Is Expressed in Medulloblastomas from Mice with Heterozygous Germ-Line Mutation of patched Cancer Res., April 1, 2000; 60(8): 2239 - 2246. [Abstract] [Full Text] |
||||
![]() |
I. D. Louro, P. McKie-Bell, H. Gosnell, B. C. Brindley, R. P. Bucy, and J. M. Ruppert The Zinc Finger Protein GLI Induces Cellular Sensitivity to the mTOR Inhibitor Rapamycin Cell Growth Differ., July 1, 1999; 10(7): 503 - 516. [Abstract] [Full Text] |
||||
![]() |
U. Stein, C. Eder, U. Karsten, W. Haensch, W. Walther, and P. M. Schlag GLI Gene Expression in Bone and Soft Tissue Sarcomas of Adult Patients Correlates with Tumor Grade Cancer Res., April 1, 1999; 59(8): 1890 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Yoon, C. Z. Liu, J. T. Yang, R. Swart, P. Iannaccone, and D. Walterhouse GLI Activates Transcription through a Herpes Simplex Viral Protein 16-Like Activation Domain J. Biol. Chem., February 6, 1998; 273(6): 3496 - 3501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Lee, K. Platt, P Censullo, and A Ruiz i Altaba Gli1 is a target of Sonic hedgehog that induces ventral neural tube development Development, January 7, 1997; 124(13): 2537 - 2552. [Abstract] [PDF] |
||||
![]() |
D. Epstein, E Marti, M. Scott, and A. McMahon Antagonizing cAMP-dependent protein kinase A in the dorsal CNS activates a conserved Sonic hedgehog signaling pathway Development, January 9, 1996; 122(9): 2885 - 2894. [Abstract] [PDF] |
||||
![]() |
N. Pavletich and C. Pabo Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers Science, September 24, 1993; 261(5129): 1701 - 1707. [Abstract] [PDF] |
||||
![]() |
X.-Q. Wang and J. A Rothnagel Post-transcriptional Regulation of the GLI1 Oncogene by the Expression of Alternative 5' Untranslated Regions J. Biol. Chem., January 5, 2001; 276(2): 1311 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gisselsson, L. Pettersson, M. Hoglund, M. Heidenblad, L. Gorunova, J. Wiegant, F. Mertens, P. Dal Cin, F. Mitelman, and N. Mandahl Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity PNAS, May 9, 2000; 97(10): 5357 - 5362. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gisselsson, T. Jonson, A. Petersen, B. Strombeck, P. Dal Cin, M. Hoglund, F. Mitelman, F. Mertens, and N. Mandahl Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors PNAS, October 23, 2001; 98(22): 12683 - 12688. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |